The approval of Mifegyne® was the successful outcome of a long struggle. Its launch in France in 1989, soon followed by other European countries, was the final point of several decades of harsh debate ...
HOOFDDORP, Netherlands, March 26, 2019 /PRNewswire/ -- Exelgyn, a global pharmaceutical company specializing in women's healthcare, has announced the launch of Abort-Report.eu, a website aiming to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results